Breast Cancer Clinical Trial

Myofascial Massage for Pain and Immobility Following Breast Cancer Surgery

Summary

About 25-50% of women who undergo breast cancer surgery develop persistent chest wall pain and shoulder mobility limitations following surgery. The pain and mobility limitations adversely affect quality of life, sleep, and body image. Unfortunately, current treatments for pain and mobility limitations have variable efficacy. Based on a review of relevant pre-, intra-, and post-operative factors, investigators reasoned that myofascial massage may address contributors to pain and mobility limitations following breast cancer surgery. Investigators propose a randomized controlled trial looking at myofascial massage compared to a light touch group to look at the effects on pain and immobility following breast cancer surgery.

View Full Description

Full Description

Myofascial massage is a deep tissue massage that focuses on muscles as well as the connective tissue that surrounds muscles, bones, and ligaments. The study team subsequently conducted a pilot randomized controlled trial involving 21 women with persistent pain and mobility limitations many months after surgery. They found that women who received myofascial massage to the affected breast/chest/shoulder had marked reductions in pain and mobility limitations and significant improvements in quality of life compared to a control group who received relaxation massage. They also established a practice-based research network of over 50 northeast Ohio massage therapists to guide future work.

The study team now proposes a full scale randomized controlled trial involving 202 women with persistent pain and mobility limitations at 2 participating sites. To help differentiate between the specific effects of myofascial massage and non-specific effects due to prolonged touch and attention from a massage therapist, the study will include an active control group that will receive light touch. Participants in each group will receive 30 minutes of treatment twice weekly for 2 months. Primary analyses will determine the impact of myofascial massage on pain and mobility limitations. Secondary analyses will examine the impact of myofascial massage on a number of secondary outcomes, including range of motion, quality of life, sleep, and body image.

Innovative features of the proposed project include a rigorous randomized controlled trial design, inclusion of an active control group, direct targeting of the affected breast/chest/shoulder, assessment of multiple mechanistic and patient-centered outcomes, and involvement of a massage practice-based research network. Investigators anticipate that the project will lead to a new and effective approach for addressing a major source of morbidity for women with breast cancer. Furthermore, the project may serve as a model for future trials of manual therapy among individuals with chronic medical conditions.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years or older
Female
Undergone breast cancer surgery 3-18 months ago
Completed all treatment for breast cancer within the last 18 months (i.e. radiation, IV chemotherapy, surgery)
Not expected to have any additional surgery (i.e. planning for reconstruction)
Self reported chronic pain or immobility since surgery

Exclusion Criteria:

Under age 18
Not female
Surgery < 3 months ago
End all cancer treatments (surgery, radiation, chemotherapy) > 18 months ago
Presence of lymphedema
Open wounds or sores
Currently on anticoagulants
Currently receiving massage treatments

Study is for people with:

Breast Cancer

Estimated Enrollment:

202

Study ID:

NCT04233385

Recruitment Status:

Recruiting

Sponsor:

MetroHealth Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

MetroHealth Medical Center
Cleveland Ohio, 44109, United States More Info
Jacqueline Dolata, MBA
Contact
216-778-1792
[email protected]
Darerian Schueller, MPH
Contact
216-778-8456
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

202

Study ID:

NCT04233385

Recruitment Status:

Recruiting

Sponsor:


MetroHealth Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.